Clinical Trial Update: Study in Schizophrenic In-patients Treated With Quetiapine Prolong or Oral Risperidone at Flexible Dose [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing quetiapine prolonged-release to oral risperidone in inpatient schizophrenia patients was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Quetiapine prolonged-release (Quetiapine)
• RISPERIDONE (RISPERIDONE)

Snippet

Sponsor: AstraZeneca | Conditions: Schizophrenic Disorders | Phase 3 | Status: TERMINATED | Results posted: 2010-09-17